OTCM
HXBM
Market cap5mUSD
Feb 07, Last price
23.27USD
Name
Helix BioMedix Inc
Chart & performance
P/E
—
P/S
6.48
EPS
—
Vol. 1Y
—
Shs. 5Y
1.82%
Rev. 5Y
-15.16%
Div Yld LY
—
Div Yld TTM
—
Revenues
807k
+0.37%
Net income
-552k
L-43.86%
CFO
-601k
L-30.93%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Helix BioMedix, Inc. is a biopharmaceutical company, which focuses on drug development for treatment of rare dermatological diseases, such as Xeroderma Pigmentosum. The company was founded in 1988 and is headquartered in Bothell, WA.
Key people
R Stephen Beatty
President, Chief Executive Officer, Acting Chief Financial Officer, Director · since 2008
Robin L. Carmichael
Chief Operating Officer, Vice President · since 2011
Randall L-W. Caudill
Independent Director · since 2001
John F. Clifford
Independent Director · since 2007
Independent Director · since 2005
Lawrence Blake Jones
Independent Director · since 2010
Jeffrey A. Miller
Independent Director · since 1999
Barry L. Seidman
Independent Director · since 2004
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||